Enhancement of morphine-induced antinociception after electroconvulsive shock in mice. 2021

Ken Iwata, and Yukio Takamatsu, and Nagafumi Doi, and Kazutaka Ikeda
Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.

Electroconvulsive therapy (ECT) has been applied for chronic pain for decades. The amounts of opioids to treat pain are sometimes reduced after a series of ECT. The effect of ECT on morphine-induced analgesia and its mechanism underlying the reduction of morphine requirement has yet to be clarified. Therefore, we administered electroconvulsive shocks (ECS) to mice and investigated the antinociceptive effect of morphine in a hot plate test. We examined the expression level of µ-opioid receptor in the thalami of mice 25 h after administration of ECS compared to the thalami of mice without ECS administration using western blotting. ECS disturbed the development of a decrease in the percentage of maximal possible effect (%MPE), which was observed 24 h after a morphine injection, when ECS was applied 25, 23, 21, and 12 h before the second administration of morphine. We also examined the effect of ECS on the dose-response curve of %MPE to morphine-antinociception. Twenty-five hours after ECS, the dose-response curve was shifted to the left, and the EC50 of morphine given to ECS-pretreated mice decreased by 30.1% compared to the mice that were not pretreated with ECS. We also found that the expression level of µ-opioid receptors was significantly increased after ECS administration. These results confirm previous clinical reports showing that ECT decreased the required dose of opioids in neuropathic pain patients and suggest the hypothesis that this effect of ECT works through the thalamus.

UI MeSH Term Description Entries
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009020 Morphine The principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle. Morphine Sulfate,Duramorph,MS Contin,Morphia,Morphine Chloride,Morphine Sulfate (2:1), Anhydrous,Morphine Sulfate (2:1), Pentahydrate,Oramorph SR,SDZ 202-250,SDZ202-250,Chloride, Morphine,Contin, MS,SDZ 202 250,SDZ 202250,SDZ202 250,SDZ202250,Sulfate, Morphine
D004597 Electroshock Induction of a stress reaction in experimental subjects by means of an electrical shock; applies to either convulsive or non-convulsive states. Electroconvulsive Shock,Electroconvulsive Shocks,Electroshocks,Shock, Electroconvulsive,Shocks, Electroconvulsive
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013788 Thalamus Paired bodies containing mostly GRAY MATTER and forming part of the lateral wall of the THIRD VENTRICLE of the brain. Thalamencephalon,Thalamencephalons
D017450 Receptors, Opioid, mu A class of opioid receptors recognized by its pharmacological profile. Mu opioid receptors bind, in decreasing order of affinity, endorphins, dynorphins, met-enkephalin, and leu-enkephalin. They have also been shown to be molecular receptors for morphine. Morphine Receptors,Opioid Receptors, mu,Receptors, Morphine,Receptors, mu,Receptors, mu Opioid,mu Receptors,Morphine Receptor,mu Opioid Receptor,mu Receptor,Opioid Receptor, mu,Receptor, Morphine,Receptor, mu,Receptor, mu Opioid,mu Opioid Receptors
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D059225 Nociception Sensing of noxious mechanical, thermal or chemical stimuli by NOCICEPTORS. It is the sensory component of visceral and tissue pain (NOCICEPTIVE PAIN). Nociperception,Nociceptions,Nociperceptions

Related Publications

Ken Iwata, and Yukio Takamatsu, and Nagafumi Doi, and Kazutaka Ikeda
November 1998, Pharmacology,
Ken Iwata, and Yukio Takamatsu, and Nagafumi Doi, and Kazutaka Ikeda
June 1998, Pharmacology, biochemistry, and behavior,
Ken Iwata, and Yukio Takamatsu, and Nagafumi Doi, and Kazutaka Ikeda
May 1976, Neuropharmacology,
Ken Iwata, and Yukio Takamatsu, and Nagafumi Doi, and Kazutaka Ikeda
April 1990, European journal of pharmacology,
Ken Iwata, and Yukio Takamatsu, and Nagafumi Doi, and Kazutaka Ikeda
October 1983, The Journal of pharmacology and experimental therapeutics,
Ken Iwata, and Yukio Takamatsu, and Nagafumi Doi, and Kazutaka Ikeda
June 1993, The Journal of pharmacology and experimental therapeutics,
Ken Iwata, and Yukio Takamatsu, and Nagafumi Doi, and Kazutaka Ikeda
January 1991, Journal of psychopharmacology (Oxford, England),
Ken Iwata, and Yukio Takamatsu, and Nagafumi Doi, and Kazutaka Ikeda
December 2008, Biological & pharmaceutical bulletin,
Ken Iwata, and Yukio Takamatsu, and Nagafumi Doi, and Kazutaka Ikeda
August 1966, Life sciences,
Ken Iwata, and Yukio Takamatsu, and Nagafumi Doi, and Kazutaka Ikeda
August 1993, Neuroscience letters,
Copied contents to your clipboard!